Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 21 results.
User Information
Export Records
  1. 1.   Human immunodeficiency virus reservoir might be actively eradicated as residual malignant cells by cytotoxic chemotherapy
  2. Yang, Q.
  3. Medical Hypotheses. 2004 62(3): 358-363.
  1. 2.   IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primates
  2. Fry, T. J.; Moniuszko, M.; Creekmore, S.; Donohue, S. J.; Douek, D. C.; Giardina, S.; Hecht, T. T.; Hill, B. J.; Komschlies, K.; Tomaszewski, J.; Franchini, G.; Mackall, C. L.
  3. Blood. 2003 101(6): 2294-2299.
  1. 3.   Eradication of human immunodeficiency virus type 1-infected cells by a combination of antimetabolic cytotoxic chemotherapy and antiviral chemotherapy in vitro: A pilot study
  2. Yang, Q. E.; Li, K. G.; Mikovits, J. A.
  3. Journal of Infectious Diseases. 2002 186(5): 706-709.
  1. 4.   NK inhibitory-receptor blockade for purging of leukemia: Effects on hematopoietic reconstitution
  2. Koh, C. Y.; Raziuddin, A.; Welniak, L. A.; Blazar, B. R.; Bennett, M.; Murphy, W. J.
  3. Biology of Blood and Marrow Transplantation. 2002 8(1): 17-25.
  1. 5.   The role of growth hormone in T-cell development and reconstitution
  2. Welniak, L. A.; Sun, R.; Murphy, W. J.
  3. Journal of Leukocyte Biology. 2002 71(3): 381-387.
  1. 6.   Interleukin-7 restores immunity in athymic T-cell-depleted hosts
  2. Fry, T. J.; Christensen, B. L.; Komschlies, K. L.; Gress, R. E.; Mackall, C. L.
  3. Blood. 2001 97(6): 1525-1533.
  1. 7.   Role of interleukin-12 in acute graft-versus-host disease
  2. Welniak, L. A.; Blazar, B. R.; Wiltrout, R. H.; Anver, M. R.; Murphy, W. J.
  3. Transplantation Proceedings. 2001 33(1-2): 1752-1753.
  1. 8.   Evidence for increased T cell turnover and decreased thymic output in HIV infection
  2. Douek, D. C.; Betts, M. R.; Hill, B. J.; Little, S. J.; Lempicki, R.; Metcalf, J. A.; Casazza, J.; Yoder, C.; Adelsberger, J. W.; Stevens, R. A.; Baseler, M. W.; Keiser, P.; Richman, D. D.; Davey, R. T.; Koup, R. A.
  3. Journal of Immunology. 2001 167(11): 6663-6668.
  1. 9.   Keratinocyte growth factor facilitates alloengraftment and ameliorates graft-versus-host disease in mice by a mechanism independent of repair of conditioning-induced tissue injury
  2. Panoskaltsis-Mortari, A.; Taylor, P. A.; Rubin, J. S.; Uren, A.; Welniak, L. A.; Murphy, W. J.; Farrel, C. T.; Lacey, D. L.; Blazar, B. R.
  3. Blood. 2000 96(13): 4350-4356.
  1. 10.   Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions
  2. Blazar, B. R.; Lees, C. J.; Martin, P. J.; Noelle, R. J.; Kwon, B.; Murphy, W.; Taylor, P. A.
  3. Journal of Immunology. 2000 165(9): 4901-4909.
  1. 11.   Longitudinal changes in CD4(+) T cell antigen receptor diversity and naive/memory cell phenotype during 9 to 26 months of antiretroviral therapy of HIV-infected patients
  2. Gea-Banacloche, J. C.; Martino, L.; Mican, J. M.; Hallahan, C. W.; Baseler, M.; Stevens, R.; Lambert, L.; Polis, M.; Lane, H. C.; Connors, M.
  3. Aids Research and Human Retroviruses. 2000 16(17): 1877-1886.
  1. 12.   Revisiting graft-versus-host disease models of autoimmunity: new insights in immune regulatory processes
  2. Murphy, W. J.
  3. Journal of Clinical Investigation. 2000 106(6): 745-747.
  1. 13.   Growth hormone as an immunomodulating therapeutic agent
  2. Murphy, W. J.; Longo, D. L.
  3. Immunology Today. 2000 21(5): 211-213.
  1. 14.   Effects of growth hormone and prolactin on hematopoiesis
  2. Welniak, L. A.; Tian, Z. G.; Sun, R.; Keller, J. R.; Richards, S.; Ruscetti, F. W.; Murphy, W. J.
  3. Leukemia & Lymphoma. 2000 38(5-6): 435-445.
  1. 15.   Abrogation of the hematological and biological activities of the interleukin-3/granulocyte-macrophage colony-stimulating factor fusion protein PIXY321 by neutralizing anti-PIXY321 antibodies in cancer patients receiving high-dose carboplatin
  2. Miller, L. L.; Korn, E. L.; Stevens, D. S.; Janik, J. E.; Gause, B. L.; Kopp, W. C.; Holmlund, J. T.; Curti, B. D.; Sznol, M.; Smith, J. W.; Urba, W. J.; Donegan, S. E.; Watson, T. M.; Longo, D. L.
  3. Blood. 1999 93(10): 3250-3258.
  1. 16.   New strategies for preventing graft-versus-host disease
  2. Murphy, W. J.; Blazar, B. R.
  3. Current Opinion in Immunology. 1999 11(5): 509-515.
  1. 17.   Retrovirus-Mediated Transfer of the Herpes Simplex Type I Thymidine Kinase Gene in Alloreactive T Lymphocytes
  2. Contassot, E.; Ferr, C.; Certoux, J. M.; Reynolds, C. W.; Jacob, W.; Chiang, Y. W.; Cahn, J. Y.; Herve, P.; Tiberghien, P.
  3. Human Gene Therapy. 1998 9(1): 73-80.
  1. 18.   A Closed Culture System For the Ex Vivo Transduction and Expansion of Human T Lymphocytes
  2. Robinet, E.; Certoux, J. M.; Ferr, C.; Maples, P.; Hardwick, A.; Cahn, J. Y.; Reynolds, C. W.; Jacob, W.; Herve, P.; Tiberghien, P.
  3. Journal of Hematotherapy. 1998 7(3): 205-215.
  1. 19.   Tumor Vaccination Strategies Combined With Autologous Peripheral Stem Cell Transplantation
  2. Kwak, L. W.
  3. Annals of Oncology. 1998 9(Suppl 1): 41-46.
  1. 20.   In Vivo Alloreactive Potential of Ex Vivo Expanded Primary T Lymphocytes
  2. Contassot, E.; Murphy, W.; Angonin, R.; Pavy, J. J.; Bittencourt, M. C.; Robinet, R.; Reynolds, C. W.; Cahn, J. Y.; Herve, P.; Tiberghien, P.
  3. Transplantation. 1998 65(10): 1365-1370.
  1. 21.   Thymidine Kinase (Tk) Gene-Transduced Human Lymphocytes Can Be Highly Purified, Remain Fully Functional, and Are Killed Efficiently With Ganciclovir
  2. Munshi, N. C.; Govindarajan, R.; Drake, R.; Ding, L. M.; Iyer, R.; Saylors, R.; Kornbluth, J.; Marcus, S.; Chiang, Y.; Ennist, D.; Kwak, L.; Reynolds, C.; Tricot, G.; Barlogie, B.
  3. Blood. 1997 89(4): 1334-1340.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel